Pinelopi Manousou

Pinelopi Manousou

Imperial College London - London / United Kingdom
Medical and Health Sciences / Gastroenterology
AD Scientific Index ID: 1237175
person_outline Pinelopi Manousou's MOST POPULAR ARTICLES
1-) Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosisV Arvaniti, G D\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Amico, G Fede, P Manousou, E Tsochatzis, M Pleguezuelo, ...Gastroenterology 139 (4), 1246-1256. e5, 201011592010
2-) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trialZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...The Lancet 394 (10215), 2184-2196, 20196782019
3-) Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem studyB Hanley, KN Naresh, C Roufosse, AG Nicholson, J Weir, GS Cooke, ...The Lancet Microbe 1 (6), e245-e253, 20204382020
4-) Transjugular liver biopsy–indications, adequacy, quality of specimens, and complications–a systematic reviewG Kalambokis, P Manousou, S Vibhakorn, L Marelli, E Cholongitas, ...Journal of hepatology 47 (2), 284-294, 20074342007
5-) Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trialsSA Harrison, VWS Wong, T Okanoue, N Bzowej, R Vuppalanchi, ...Journal of hepatology 73 (1), 26-39, 20203822020